A. Sinclair Dunlop, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 136,000 shares at $28.55 ($4.0M) on 2019-12-18, disclosed to the SEC on 2019-12-20.
Open-market sale of $4.0M APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.55 | 25,890 | $739K | 18.7% |
| 2 | $28.99 | 54,110 | $1.6M | 39.6% |
| 3 | $29.51 | 31,000 | $915K | 23.1% |
| 4 | $29.53 | 25,000 | $738K | 18.6% |
| Total | $29.12 avg | 136,000 | $4.0M | 100% |
| Filing → |
| APLS | SELL | 2025-09-19 | $1.4M | — | Filing → |
| APLS | SELL | 2024-09-17 | $2.7M | — | Filing → |
| APLS | SELL | 2024-06-21 | $2.9M | — | Filing → |